BioCentury | May 29, 2020
Distillery Therapeutics

Epigenetic protein PHF20L1 identified as breast cancer target

DISEASE CATEGORY: Cancer INDICATION: Breast cancer Inhibiting PHF20L1, an epigenetic protein that recognizes methylated histone residues, could treat breast cancer. In breast cancer patients, high tumor levels of PHF20L1 protein were associated with high histological...
Items per page:
1 - 1 of 1